Skip to main content
Figure 1 | BMC Pulmonary Medicine

Figure 1

From: Oral intake of phenylbutyrate with or without vitamin D3upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis

Figure 1

Plasma 25-hydroxyvitamin D 3 concentration in healthy adults before and after supplementation. Group-I: 250 mg PB b.d. + 5000 IU vitamin D3 o.d.; Group-II: 500 mg PB b.d. + 5000 IU vitamin D3 o.d.; Group-III: 1000 mg PB b.d. + 5000 IU vitamin D3 o.d.; Group-IV: 500 mg PB b.d.; Group-V: 5000 IU vitamin D3 o.d. PB: Phenylbutyrate. b.d.: twice daily. o.d. : once daily. Data were analyzed by One-way ANOVA.

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us